Literature DB >> 9950844

A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations.

S Firoozan1, K Wei, A Linka, D Skyba, N C Goodman, S Kaul.   

Abstract

The controversy regarding the mechanism(s) of left ventricular (LV) dysfunction in chronic coronary artery disease is, in part, related to the lack of an appropriate animal model for this condition. We have developed such a model by placing Ameroid constrictors on proximal portions of coronary arteries in dogs who were euthanized (mean of 6 wk) after the development of severe global LV dysfunction noted on two-dimensional echocardiography. The LV end-systolic size nearly doubled (P < 0.001) over the observation period, and the percent change in LV size from end diastole to end systole decreased by >50% (P < 0.001). Regional dysfunction was noted in 23 of 24 myocardial beds analyzed within regions showing no gross evidence of infarction. In 10 of these beds, severe dysfunction was noted without a decrease in radiolabeled microsphere-derived myocardial blood flow (MBF). In 13 myocardial beds, decrease in function was associated with a decrease in MBF (P < 0.001), with close coupling noted between percent wall thickening and MBF. In the beds that exhibited an ultimate decrease in MBF, the decrease in function preceded the decrease in MBF. In conclusion, we describe chronic LV dysfunction in a canine model of multivessel stenosis that closely mimics chronic ischemic LV dysfunction in humans. Whereas regional function is severely reduced in this model, MBF is varied in different segments and at different times during the observation period. These results provide new insights regarding flow-function relations in chronic ischemic LV dysfunction.

Entities:  

Mesh:

Year:  1999        PMID: 9950844     DOI: 10.1152/ajpheart.1999.276.2.H446

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

Review 1.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

Review 3.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  Evaluation of hibernating myocardium.

Authors:  J J Bax; D Poldermans; E E van der Wall
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

Review 5.  Echocardiographic insights into regional flow-function relationships in coronary artery disease.

Authors:  Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

6.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

7.  Assessment of myocardial viability by nuclear imaging techniques.

Authors:  Jeroen J Bax; Don Poldermans; Abdou Elhendy; Eric Boersma; Ernst E van der Wall
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

Review 8.  Myocardial hibernation in coronary artery disease.

Authors:  Dinesh K Kalra; William A Zoghbi
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

9.  Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol.

Authors:  D Elizabeth Le; Marco Pascotto; Howard Leong-Poi; Ibrahim Sari; Antonio Micari; Sanjiv Kaul
Journal:  Basic Res Cardiol       Date:  2013-09-27       Impact factor: 17.165

10.  Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium.

Authors:  M Bountioukos; A F L Schinkel; J J Bax; V Rizzello; R Valkema; B J Krenning; E Biagini; E C Vourvouri; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.